- 全部删除
您的购物车当前为空
Vantictumab (OMP-18R5) 是一种人源化抗 FZD1/2/5/7/8 单克隆抗体,抑制 Wnt 通路信号传导,可用于研究治疗转移性HER2阴性乳腺癌和转移性胰腺腺癌。
Vantictumab (OMP-18R5) 是一种人源化抗 FZD1/2/5/7/8 单克隆抗体,抑制 Wnt 通路信号传导,可用于研究治疗转移性HER2阴性乳腺癌和转移性胰腺腺癌。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,480 | In stock | |
| 5 mg | ¥ 5,860 | In stock | |
| 10 mg | ¥ 7,890 | In stock | |
| 25 mg | ¥ 11,700 | In stock |
Vantictumab 相关产品
| 产品描述 | Vantictumab (OMP-18R5) is a humanized anti-FZD1/2/5/7/8 monoclonal antibody that inhibits Wnt pathway signaling and is used in research studies for the treatment of metastatic HER2-negative breast cancer and metastatic pancreatic adenocarcinoma. |
| 别名 | 万替妥单抗, OMP18R5 |
| CAS No. | 1345009-45-1 |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容